News - UF Innovate

NCI Grant Supports UF Health Cancer Center Epigenetics Research

Richard Bennett, Ph.D., a research associate professor in the Division of Hematology/Oncology in the UF College of Medicine, has received a prestigious five-year, $850,000 grant from the National Cancer Institute (NCI) to support research investigating epigenetic mechanisms of cancer.

How Our Brains Learn New Athletic Skills Fast

According to a study from the University of Florida biomechanical researchers, the quick, athletic learners among us are built differently – inside their brains.

Natural Ponds Remove Nitrogen More Effectively Than Stormwater Ponds, Researchers Find

Designed to control flooding, stormwater ponds are not as effective as natural ponds at removing nitrogen, a pollutant that can go downstream into lakes, rivers and other bodies of water, new University of Florida research shows.

What the Trained Eye Cannot See: Detecting Movement Defects in Early-Stage Parkinson’s Disease

A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson’s disease could help reveal signs of the disease and other movement disorders earlier, which could lead to better treatment outcomes.

Beer in Space: UF Researchers Study Microgravity’s Effect on Fermentation

A recently published study by University of Florida researchers provides insight into how beer yeast might behave when fermented in outer space.

Synthetic “Alien” DNA Provides Opportunities for Disease Diagnostics and Treatment

To help understand how DNA may have evolved on other planets, UF researcher Dr. Steven Benner and his partners synthesized DNA-like molecular systems with more than four nucleotides in the laboratory.

New $7.7 Million Grant To Propel Search for Drugs for Rare Brain Disorder

Rumbaugh and a team of scientists from the institute have been awarded a five-year grant from the National Institute of Mental Health worth $7.7 million to work toward a treatment. Their goal is to create a pill that restores healthy SYNGAP1 gene production, thereby boosting neuroplasticity, or the ability of the brain to form circuits and connections.

Atsena Therapeutics Receives Rare Pediatric Disease Designation From the U.S. FDA for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation (RPD) for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

Grant Funds University of Florida Research for Potential Opioid Relief

The USDA National Institute of Food and Agriculture has awarded a $650,000 grant to a UF/IFAS researcher to study a plant that could help mitigate the opioid epidemic, a national health crisis responsible for more than 130 deaths each day.

Tech Tuesday: Local Nonprofit Is Enhancing the Healthcare Experience Through Technology

In this week’s Tech Tuesday, host Bethany Gaffey introduces Dream Team Engineering’s Ashni Zaverchand, president of the nonprofit creating technologies to enhance the healthcare experience for patients and physicians.

UF News